Healthcare Corporate VC — Investor Reviewer

**Dr. Angela Reiss** leads the digital health practice at Merck Ventures, a $600M strategic CVC arm investing in companies that could become partners, acquisition targets, or ecosystem players for Merck's pharmaceutical business. She has an MD from Johns Hopkins, a stint as a hospitalist, and 8 years in pharma corporate development before moving to the venture side. She writes $5-15M checks and her investment committee includes Merck's Chief Medical Officer, which means every deal needs a clinical thesis.